1. Home
  2. SYPR vs RLYB Comparison

SYPR vs RLYB Comparison

Compare SYPR & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYPR
  • RLYB
  • Stock Information
  • Founded
  • SYPR 1997
  • RLYB 2018
  • Country
  • SYPR United States
  • RLYB United States
  • Employees
  • SYPR N/A
  • RLYB N/A
  • Industry
  • SYPR Industrial Machinery/Components
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SYPR Industrials
  • RLYB Health Care
  • Exchange
  • SYPR Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • SYPR 52.5M
  • RLYB 45.2M
  • IPO Year
  • SYPR 1994
  • RLYB 2021
  • Fundamental
  • Price
  • SYPR $2.03
  • RLYB $0.92
  • Analyst Decision
  • SYPR
  • RLYB Buy
  • Analyst Count
  • SYPR 0
  • RLYB 6
  • Target Price
  • SYPR N/A
  • RLYB $8.10
  • AVG Volume (30 Days)
  • SYPR 68.3K
  • RLYB 125.7K
  • Earning Date
  • SYPR 11-12-2024
  • RLYB 11-07-2024
  • Dividend Yield
  • SYPR N/A
  • RLYB N/A
  • EPS Growth
  • SYPR N/A
  • RLYB N/A
  • EPS
  • SYPR N/A
  • RLYB N/A
  • Revenue
  • SYPR $141,466,000.00
  • RLYB $598,000.00
  • Revenue This Year
  • SYPR N/A
  • RLYB N/A
  • Revenue Next Year
  • SYPR N/A
  • RLYB N/A
  • P/E Ratio
  • SYPR N/A
  • RLYB N/A
  • Revenue Growth
  • SYPR 7.82
  • RLYB N/A
  • 52 Week Low
  • SYPR $1.27
  • RLYB $0.84
  • 52 Week High
  • SYPR $2.93
  • RLYB $3.46
  • Technical
  • Relative Strength Index (RSI)
  • SYPR 65.05
  • RLYB 39.08
  • Support Level
  • SYPR $1.84
  • RLYB $0.84
  • Resistance Level
  • SYPR $2.93
  • RLYB $1.24
  • Average True Range (ATR)
  • SYPR 0.25
  • RLYB 0.08
  • MACD
  • SYPR 0.04
  • RLYB -0.02
  • Stochastic Oscillator
  • SYPR 36.17
  • RLYB 19.80

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sale of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: